发明申请
US20140187583A1 Polymorph Form of 4-methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid
有权
4-甲基）哌啶-1-基]甲基} - 四氢-2H-吡喃-4-羧酸的多晶型
![Polymorph Form of 4-methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid](/docs/US/2014-07-03/US20140187583A1/abs.jpg.600x600.jpg)
- 专利标题： Polymorph Form of 4-methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid
- 专利标题（中）： 4-甲基）哌啶-1-基]甲基} - 四氢-2H-吡喃-4-羧酸的多晶型
-
申请号： US14118377申请日： 2012-05-18
-
公开(公告)号： US20140187583A1公开(公告)日： 2014-07-03
- 发明人: Toyoharu Numata , Hirohide Noguchi , Nobuaki Waizumi , Takashi Kojima
- 申请人： Toyoharu Numata , Hirohide Noguchi , Nobuaki Waizumi , Takashi Kojima
- 申请人地址： JP Aichi
- 专利权人： RAQUALIA PHARMA INC.
- 当前专利权人： RAQUALIA PHARMA INC.
- 当前专利权人地址： JP Aichi
- 优先权： JP2011-111901 20110518
- 国际申请： PCT/JP2012/003288 WO 20120518
- 主分类号： C07D413/14
- IPC分类号： C07D413/14
![Polymorph Form of 4-methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid](/abs-image/US/2014/07/03/US20140187583A1/abs.jpg.150x150.jpg)
摘要：
The present invention relates to novel crystal forms of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. More particularly, the invention relates to polymorph forms (Polymorph Form I or Polymorph Form II), and to processes for the preparation of, compositions containing and to uses of, such polymorph forms.
公开/授权文献
信息查询
